Los iSGLT2 han revolucionado la protección cardiorrenal, pero los trasplantados renales han quedado fuera de la historia. El ensayo INFINITI empieza a cerrar esa brecha. ¿Flozinaran igual los iSGLT2 en el riñón trasplantado? Revisa el resumen visual creado por Janany Sabescumar
To INFINITI and Beyond: SGLT2 Inhibitors in Kidney Transplant Patients
CARDINAL Sin: Bardoxolone and Alport Syndrome
The NephJC Kidneys...nominations close next Wednesday
The NephJC Kidneys...late but not forgotten.
MinTac: The Visual Abstract
The trial is from cJASN, so we do have a visual abstract from Pablo Garcia, in the cJASN style
And Omar as well created another visual abstract, in his own inimitable style
PD and Volume: the Visual Abstract
CJASN had a sterling visual abstract from Michelle Rheault. Here it is
